Prospector Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-74,542
Closed -$13.8M 48
2025
Q3
$13.8M Sell
74,542
-8,788
-11% -$1.51M 1.65% 21
2025
Q2
$12.7M Sell
83,330
-8,302
-9% -$1.28M 1.46% 28
2025
Q1
$15.2M Buy
91,632
+14,400
+19% +$2.25M 1.71% 21
2024
Q4
$11.2M Buy
77,232
+10,585
+16% +$1.64M 1.24% 37
2024
Q3
$10.8M Buy
66,647
+513
+0.8% +$81.7K 1.13% 37
2024
Q2
$9.67M Buy
66,134
+660
+1% +$98.2K 1.08% 38
2024
Q1
$10.4M Buy
65,474
+4,955
+8% +$789K 1.14% 37
2023
Q4
$9.49M Buy
60,519
+25,225
+71% +$3.87M 1.18% 37
2023
Q3
$5.5M Sell
35,294
-5,840
-14% -$964K 0.74% 53
2023
Q2
$6.81M Buy
41,134
+350
+0.9% +$56.5K 0.95% 48
2023
Q1
$6.32M Buy
40,784
+300
+0.7% +$48.4K 0.88% 49
2022
Q4
$7.15M Sell
40,484
-15,250
-27% -$2.63M 0.98% 43
2022
Q3
$9.11M Sell
55,734
-23,426
-30% -$3.96M 1.36% 26
2022
Q2
$14.1M Buy
79,160
+3,700
+5% +$659K 2.05% 10
2022
Q1
$13.4M Buy
75,460
+43,850
+139% +$7.46M 1.65% 19
2021
Q4
$5.41M Sell
31,610
-400
-1% -$65.5K 0.63% 60
2021
Q3
$5.17M Sell
32,010
-3,250
-9% -$554K 0.66% 55
2021
Q2
$5.81M Sell
35,260
-7,450
-17% -$1.23M 0.73% 53
2021
Q1
$7.02M Sell
42,710
-5,500
-11% -$890K 0.9% 48
2020
Q4
$7.59M Sell
48,210
-5,300
-10% -$782K 0.94% 40
2020
Q3
$7.97M Sell
53,510
-500
-0.9% -$74K 1.2% 31
2020
Q2
$7.59M Sell
54,010
-2,430
-4% -$354K 1.32% 30
2020
Q1
$7.4M Buy
56,440
+8,750
+18% +$1.24M 1.4% 27
2019
Q4
$6.96M Buy
47,690
+8,600
+22% +$1.17M 0.98% 40
2019
Q3
$5.06M Sell
39,090
-2,080
-5% -$274K 0.74% 47
2019
Q2
$5.73M Sell
41,170
-16,771
-29% -$2.32M 0.79% 44
2019
Q1
$8.1M Sell
57,941
-3,560
-6% -$477K 1.23% 28
2018
Q4
$7.94M Sell
61,501
-1,810
-3% -$252K 1.24% 30
2018
Q3
$8.75M Buy
63,311
+1,000
+2% +$133K 1.21% 25
2018
Q2
$7.56M Sell
62,311
-430
-0.7% -$53.6K 1.05% 31
2018
Q1
$8.04M Sell
62,741
-1,310
-2% -$177K 1.17% 28
2017
Q4
$8.95M Sell
64,051
-1,965
-3% -$274K 1.3% 27
2017
Q3
$8.58M Sell
66,016
-580
-0.9% -$76.9K 1.3% 29
2017
Q2
$8.81M Sell
66,596
-2,720
-4% -$347K 1.38% 23
2017
Q1
$8.63M Sell
69,316
-200
-0.3% -$23.9K 1.32% 24
2016
Q4
$8.01M Buy
69,516
+200
+0.3% +$23.1K 1.19% 27
2016
Q3
$8.19M Buy
69,316
+1,900
+3% +$231K 1.31% 23
2016
Q2
$8.18M Sell
67,416
-11,800
-15% -$1.34M 1.39% 15
2016
Q1
$8.57M Buy
79,216
+300
+0.4% +$31.1K 1.48% 16
2015
Q4
$8.11M Sell
78,916
-47,900
-38% -$4.82M 1.44% 17
2015
Q3
$11.8M Sell
126,816
-4,899
-4% -$474K 1.71% 8
2015
Q2
$12.8M Sell
131,715
-127,201
-49% -$12.7M 1.52% 18
2015
Q1
$26M Buy
258,916
+39,000
+18% +$3.97M 1.96% 8
2014
Q4
$23M Sell
219,916
-89,384
-29% -$9.42M 1.74% 11
2014
Q3
$33M Sell
309,300
-59,600
-16% -$6.18M 1.81% 8
2014
Q2
$38.6M Sell
368,900
-8,000
-2% -$809K 1.85% 8
2014
Q1
$37M Sell
376,900
-71,600
-16% -$6.64M 1.76% 8
2013
Q4
$41.1M Sell
448,500
-94,450
-17% -$8.7M 1.83% 5
2013
Q3
$47.1M Sell
542,950
-81,900
-13% -$7.35M 2.14% 5
2013
Q2
$53.6M Buy
+624,850
New +$53M 2.64% 5

Other funds holding JNJ

Prospector Partners's JNJ Position: Q4 2025 in Review

Prospector Partners sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 74,542 shares — an estimated $13.8M sold.

Prospector Partners first reported a position in JNJ in Q2 2013 and held it in 50 quarters. The position peaked at $53.6M in Q2 2013. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Prospector Partners reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
  • Prospector Partners sold 74,542 Johnson & Johnson shares in Q4 2025, an estimated $13.8M.
  • Prospector Partners first reported a position in Johnson & Johnson in Q2 2013 and held it in 50 quarters.
  • Prospector Partners's Johnson & Johnson position peaked at $53.6M in Q2 2013.
  • 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Prospector Partners's 13F filing for Q4 2025, filed 13 Feb 2026.